|Physician Leadership||Physician Contributors|
Martin B. Leon, MD, is Founder and Chairman Emeritus of the Cardiovascular Research Foundation and Professor of Medicine at Columbia University College of Physicians and Surgeons. Dr. Leon is also the Director of the Center for Interventional Vascular Therapy (CIVT) at NewYork-Presbyterian Hospital/Columbia University Medical Center in New York City. In addition, Dr. Leon serves as Director of the Cardiac Catheterization Laboratories and is on the Executive Board of the NewYork-Presbyterian/Columbia Valve Center.
Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis.
Dr. Leon has co-authored over 1,550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding subspecialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics, the largest dedicated meeting in interventional cardiovascular medicine in the world, which will celebrate its 24th anniversary in 2012. He also has been the Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was also awarded an honorary degree from the University of Athens.
Dr. Leon was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York as well as Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. He also served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. He was a founder of the Washington Cardiology Center and the Cardiology Research Foundation in Washington, DC.
Dr. Leon completed a fellowship in Cardiology at the Yale-New Haven Hospital. He completed medical school at the Yale School of Medicine, and his internship and residency in internal medicine at the Yale-New Haven Hospital.
Gregg W. Stone, MD, FACC, FSCAI, is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital/Columbia University Medical Center. He also serves as Co-Director, Medical Research & Education Division at the Cardiovascular Research Foundation in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 50 national and international multicenter randomized trials, has authored more than 1000 book chapters, manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world.
Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug eluting stents; adjunct pharmacology; percutaneous heart valves, new device angioplasty including distal embolic protection, thrombectomy, vascular brachytherapy and stent grafts; intravascular ultrasound imaging; saphenous vein graft therapies; chronic total occlusions; vulnerable plaque; contrast nephropathy; clinical trial design; and regulatory issues.
Dr. Stone, along with Dr. Martin B. Leon, is the director of Transcatheter Cardiovascular Therapeutics (TCT), the world's largest symposium devoted to interventional cardiovascular medicine, directs the annual Interventional Cardiology Fellows Course, and co-directs several other annual courses, including Optimizing PCI Outcomes, the Chronic Total Occlusion Summit, and Transcatheter Valve Therapies.
Dr. Stone previously held similar positions at Lenox Hill Hospital in New York and the Washington Hospital Center in Washington, DC. Previously he was the Director of Interventional Cardiology at the Cardiovascular Institute at El Camino Hospital and Stanford University Medical Center in California.
Dr. Stone completed medical school at Johns Hopkins University Medical Center, in Baltimore, MD, and his internship and residency at the New York Hospital-Cornell Medical Center in New York City. He completed his general cardiology fellowship at Cedars-Sinai Medical Center in Los Angeles, CA, under Dr. Jeremy Swan, and subsequently a dedicated fellowship in advanced coronary angioplasty with Dr. Geoffrey Hartzler in Kansas City, MO.
Jeffrey W. Moses, MD, is Professor of Medicine at Columbia University College of Physicians and Surgeons. He is also Director, Cardiovascular Interventions at NewYork-Presbyterian Hospital/Columbia University Medical Center and Weill Cornell Medical Center.
Dr. Moses has made important contributions in the areas of clinical research and educational activities in interventional vascular therapy. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, and various support devices that allow for wider application of interventional cardiovascular procedures.
Dr. Moses, an internationally-recognized interventional cardiologist, has performed more than 12,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies demonstrating the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial that was the first in the US to demonstrate the enormous benefit of the first drug-coated stent, leading to its approval by the Food and Drug Administration. That stent is now used in the majority of interventional procedures in the US.
Dr. Moses, who previously held a professorship in Clinical Medicine at New York University School of Medicine, also served in various positions at the New York Hospital (now NewYork-Presbyterian Hospital/Weill Cornell Medical Center), where he became Associate Director of the Adult Cardiac Catheterization Laboratory and Director of Clinical Electrophysiology. He is a fellow in multiple professional societies and serves on the editorial board as a reviewer for numerous peer review journals.
Dr. Moses completed medical school at the University of Pennsylvania School of Medicine, Philadelphia, PA, and finished his internship, residency and fellowship in cardiology at the Penn Presbyterian Medical Center at the University of Pennsylvania, Philadelphia, PA.
Gary S. Mintz, MD, is Chief Medical Officer of the Cardiovascular Research Foundation, Editor-in-Chief of TCTMD.com, and a Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). Dr. Mintz has extensive experience in both interventional cardiology and cardiac ultrasound and is an expert in the area of cardiovascular imaging. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program, which has studied over 30,000 patients using intravascular ultrasound and has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis.
He is the author of over 675 articles, 50 book chapters, and 625 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and intravascular ultrasound.In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound, the definitive work in the field.
Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University, in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty (with a joint appointment in the Department of Diagnostic Radiology) in 1978 and was ultimately promoted to Professor of Medicine in 1987. His administrative appointments there included Director of the Cardiac Ultrasound Laboratory, Director of the Coronary Care Unit, and Director of the Cardiology Fellowship Training Program. He received teaching awards from both the Department of Medicine Residency and Cardiology Fellowship Training Programs.
Juan F. Granada, MD, is the Executive Director and Chief Scientific Officer of the CRF Skirball Research Center. Dr. Granada is also Assistant Professor of Medicine, Division of Cardiology at Columbia University College of Physicians and Surgeons. At the CRF Skirball Research Center, Dr. Granada leads a multidisciplinary research group which aims to accelerate the validation process of promising technologies before undergoing human testing in areas such as cardiac imaging, emerging endovascular therapy and tissue regeneration.
Dr. Granada is a leading investigator in the field of animal models of atherosclerosis, advanced endovascular imaging and emerging cardiovascular therapies in which he holds numerous publications, book chapters, patents and awards (Young Investigator Award; American College of Cardiology (finalist in 2000 and 2008) and American Heart Association (VP award first place in 2002). Additionally, he has participated in the development and successful validation of several medical technologies in the areas of endovascular imaging and endovascular devices. Dr. Granada collaborates with scientists and centers around the world supporting the development of innovative concepts to diagnose and treat cardiovascular disease.
Dr. Granada is an active interventional cardiologist specializing in advanced interventional procedures. He completed medical studies at the Institute of Health Sciences in Medellin, Colombia and finished his internship and residency in internal medicine at the Marshfield Clinic, Wisconsin where he also served as a chief medical resident. He completed his cardiovascular disease and interventional cardiology fellowships at Baylor College of Medicine, Houston, Texas. He has been certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease, and interventional cardiology.
Roxana Mehran, MD, is Professor of Medicine at Mount Sinai School of Medicine, Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute, and Chief Scientific Officer of the Clinical Trial Center at the Cardiovascular Research Foundation. She was previously Associate Professor of Medicine and Director of Outcomes Research, Data Coordination and Analysis at the Center for Interventional Vascular Therapy, Columbia University Medical Center.
Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiology. She is also recognized for her experience and expertise in working with regulatory agencies to conduct clinical trials. Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction. In addition to founding a highly regarded academic research organization (ARO) within the Cardiovascular Research Foundation, she is also a widely published author in the most respected cardiovascular journals, and has authored and co-authored and co-edited a significant number of books and book chapters.
Dr. Mehran has been an invited speaker at national and international scientific conferences such as American Heart Association, American College of Cardiology, European Society of Cardiology, and EuroPCR, and has served as Course Co-Director of the annual Transcatheter Cardiovascular Therapeutics (TCT) for the last 13 years. Dr Mehran completed her training in internal medicine at the University of Connecticut, where she was Chief Medical Resident, before continuing her studies in Cardiovascular Diseases and Interventional Cardiology at Mount Sinai Medical Center in New York. She is an elected fellow of the American College of Cardiology, American College of Physicians, American Heart Association, Society of Cardiac Angiography and Intervention (SCAI), and the European Society of Cardiology. She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, and as Program Chair for SCAI's WIN (Women In Innovations) Initiative.
Sorin J. Brener, MD, is Director, Event Adjudication and Reporting at the Cardiovascular Research Foundation. Since 2008, Dr. Brener has served as the Director of Cardiac Catheterization at New York Methodist Hospital in Brooklyn, New York, a member of the NewYork-Presbyterian Healthcare System. Prior to his affiliation with New York Methodist Hospital, Dr. Brener was a senior staff cardiologist, the director of the Angiographic Core Laboratory and the head of the acute revascularization program at the Cleveland Clinic Foundation. Dr. Brener is currently a Professor of Medicine at Weill Cornell Medical College.
George D. Dangas, MD, PhD, is Professor of Medicine at the Mount Sinai School of Medicine and Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute of the Mount Sinai Medical Center in New York, NY. He is currently Director of Academic Affairs and Co-Director of Transcatheter Cardiovascular Therapeutics (TCT) as well as the Interventional Fellows Course of CRF.
Dr. Dangas is a leading authority in the performance of nonsurgical cardiac and vascular interventions (eg, stent, angioplasty, atherectomy) using both established and novel techniques and also in preventing and dissolving thrombosis in the coronary and peripheral arteries. He is currently serving as the Chair of the American College of Cardiology Interventional Scientific Council and has been a Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI). He has been a key faculty and program committee member for multiple international conferences including the ACC/i2 Summit, AHA, ACCIS, JIM, and SCAI. He has recently joined the Board of Trustees of the American College of Cardiology.
Dr. Dangas completed medical and postgraduate studies at the National Kapodistrian University of Athens, Greece. Dr. Dangas completed his internship and residency in internal medicine at Miriam Hospital and Brown University in Providence, RI. He completed his cardiovascular disease and interventional cardiology fellowships at Mount Sinai Hospital. Before joining the faculty of Mount Sinai, he was Associate Professor and Program Director of Interventional Cardiology at Columbia University Medical Center (New York, NY) and Associate Clinical Professor at NYU School of Medicine and Lenox Hill Hospital. He has been certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology, by the American Board of Vascular Medicine in both Endovascular and Vascular Medicine, and has been elected fellow of seven national and international professional societies (AHA, ACC, ACCP, ESC, SCAI, ACP-ASIM, and SVM).
Michael D. Ezekowitz, MB, ChB, DPhil, FACC is Director of Atrial Fibrillation Research and Education at CRF. As one of the leading authorities on atrial fibrillation, Dr. Ezekowitz develops major clinical research programs to improve outcomes for patients and also leads educational efforts on atrial fibrillation for both physicians and the public. In addition to atrial fibrillation, his main research interests include stroke prevention and thrombosis.
Dr. Ezekowitz also serves as Professor of Medicine at Thomas Jefferson Medical College in Philadelphia, Pennsylvania and is an Attending Cardiologist at Lankenau Medical Center, and Bryn Mawr & Paoli Hospitals. Dr. Ezekowitz received his medical degree from the University of Cape Town in South Africa and a PhD from Imperial College, London University.
Philippe Généreux, MD, is Director, Angiographic Core Laboratory at CRF. His main research interests include coronary risk stratification/Syntax score, coronary physiology and imaging, percutaneous aortic valve replacement, transradial Intervention, drug-eluting stents innovation, and medical simulation.
Dr. Généreux also serves as an Interventional Cardiologist at NewYork-Presbyterian Hospital/Columbia University Medical Center and the Hôpital du Sacré-Coeur de Montréal. He received his medical degree from the Université de Montréal, Québec, Canada and is currently pursuing a PhD at Erasmus University (Rotterdam, The Netherlands).
Greg L. Kaluza MD, PhD, is the Director of Research at the CRF Skirball Research Center.
Dr. Kaluza has presented at multiple national and international meetings and has published over 50 original and review papers in numerous scientific journals including Circulation, Journal of the American College of Cardiology, American Heart Journal, and American Journal of Cardiology. He also coauthored several book chapters and multimedia, including the Catheterization Self-Assessment Program by the American College of Cardiology (ACC). He became an ACC fellow in 2005.
Prior to coming to the Cardiovascular Research Foundation, Dr. Kaluza served as Scientific Director of the Center for Research in Cardiovascular Interventions and as Co-Director of the Core Angiographic Laboratory at the Methodist Hospital Research Institute in Houston, TX.
Dr. Kaluza received his medical degree in 1992 from the Nicolas Copernicus Academy of Medicine in Kraków, Poland. He completed his postgraduate fellowship at the Laboratory of Physiology, University of Antwerp, Belgium, and his residency in internal medicine at the Jagiellonian University College of Medicine, Kraków, Poland. He became board certified in Poland in 1997 and received his doctoral degree in the biomedical sciences from the Jagiellonian University College of Medicine, Kraków, Poland, in 1998.
Akiko Maehara, MD, is the Director of Intravascular Imaging Core Laboratory at the Cardiovascular Research Foundation and an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons in New York, NY.
Dr. Maehara has authored numerous papers related to cardiovascular interventions and the use of intravascular ultrasound.
Dr. Maehara is board certified in internal medicine and cardiology by the Japanese Society of Internal Medicine and Japanese Society of Cardiology, respectively. She received her medical degree in 1993 from Yamaguchi University School of Medicine in Yamaguchi, Japan. Dr. Maehara completed her clinical fellowship in the Toranomon Hospital in Tokyo, Japan, and a cardiovascular fellowship at the Cardiovascular Center in Toranomon Hospital, also in Tokyo. In 2000, Dr. Maehara finished a research fellowship in cardiovascular interventions at Stanford University School of Medicine in Stanford, CA, with an additional year of fellowship in the Cardiovascular Research Institute at the Washington Hospital Center, Washington, DC.